NCT05932303View on ClinicalTrials.gov

A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 12, 2023

Primary Completion Date

October 23, 2023

Study Completion Date

October 23, 2023

Conditions
Healthy Participants
Interventions
DRUG

BMS-986278

Specified dose on specified days

DRUG

Itraconazole

Specified dose on specified days

DRUG

Gemfibrozil

Specified dose on specified days

DRUG

Carbamazepine

Specified dose on specified days

Trial Locations (1)

G1P 0A2

Local Institution - 0001, Québec

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY